A 33-year-old cisgender man was recently diagnosed with HIV and disseminated Mycobacterium avium complex (MAC). His baseline laboratory studies revealed an HIV RNA level of 124,000 copies/mL, a CD4 count of 38 cells/mm3, and an HIV genotype with no mutations. He started taking clarithromycin 500 mg twice daily and ethambutol 1200 mg daily for the treatment of disseminated MAC and trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis. The plan is to initiate antiretroviral therapy in 1 week.
Assuming the patient will remain on the same regimen to treat disseminated MAC, which one of the following antiretroviral regimens would be preferred?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
August 28th, 2024
August 28th, 2024
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5